FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.
This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.
As part of its 2019 Interim Results on 22 August 2019, CRH PLC (LON:CRH) announced its intention to continue its share buyback programme with a further tranche of up to..
AstraZeneca plc (LON:AZN) today announced that it has agreed to buy a US Food and Drug Administration Priority Review Voucher for a total cash consideration of $95m from a subsidiary..
NMC Health PLC (LON:NMC), the leading Gulf Cooperation Council and international private healthcare operator, has today announced its results for the six months ended 30 June 2019. Key Highlights · Strong..
GlaxoSmithKline PLC (LON: GSK) ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced positive headline results from its..
NMC Health PLC (LON:NMC) today announced that it intends to immediately initiate the process to seek shareholder approval for a share buyback programme. The buyback authority will require formal approval..
Antofagasta PLC (LON: ANTO) have today announced its half year report for the six months ended 30th June 2019. Antofagasta plc CEO Iván Arriagada said: “We have delivered robust financial..
AstraZeneca (LON: AZN) today announced that its partner FibroGen (China) Medical Technology Development Co., Ltd. (FibroGen China) has received marketing authorisation for roxadustat in China for the treatment of anaemia..
AstraZeneca plc (LON: AZN) today announced final overall survival results from the Phase III NEPTUNE trial, a randomised, open-label, multi-centre, global trial of Imfinzi (durvalumab) in combination with tremelimumab, an..
BHP Group (LON: BHP) have today announced that its ‘Results Presentation Year Ended 30 June 2019’ has today been submitted to the National Storage Mechanism and will shortly be available..
Persimmon Plc (LON:PSN) today announced its half year results for the six months ended 30 June 2019. Highlights “Improving the quality and service delivered to our customers remains our top..
Farxiga met primary endpoint in landmark Phase III DAPA-HF trial for the treatment of patients with heart failure DAPA-HF is the first heart failure outcomes trial with an SGLT2 inhibitor..
AstraZeneca plc (LON:AZN) today announced that, with effect from 1 September 2019, Michel Demaré is appointed as a Non-Executive Director and a member of the Audit Committee. Leif Johansson, Chairman..
United Utilities Group PLC (LON: UU.) announced today that in accordance with Listing Rule 9.6.14(2) Dr John McAdam, chairman, has been appointed as chairman of ConvaTec Group Plc with effect..
On 15 August 2019, Standard Life Aberdeen plc (LON:SLA) entered into a non-discretionary instruction with Citigroup Global Markets Limited in relation to the purchase by Citi, acting as principal, of..
Anglo American plc (LON: AAL) announced today that it has purchased the following number of its ordinary shares of US$0.54945 each on Exchange (as defined in the Rules of the..
Berkeley Group Holdings (LON: BKG) have today announced that an interim dividend of 20.08 pence per share will be paid on 13 September 2019 to shareholders on the Company’s register..
Admiral Group plc (LON:ADM) today announced its results for the six months ended 30 June 2019. 30 June 2019 30 June 2018 % change Group’s share of profit before tax*1..
Anglo American plc (LON: AAL) announced today that it has purchased the following number of its ordinary shares of US$0.54945 each on Exchange (as defined in the Rules of the..
AstraZeneca plc (LON:AZN) today announced that the US Food and Drug Administration has granted Breakthrough Therapy Designation for Calquence as a monotherapy treatment for adult patients with chronic lymphocytic leukaemia,..
AstraZeneca plc (LON:AZN) and MSD Inc., known as Merck & Co., Inc. inside the US and Canada, today announced positive results from the Phase III PAOLA-1 trial in women with..
